Comparison of different lymphoma cell purging modalities: An experimental study with K422 lymphoma cells

Acta Haematologica

Volumn 101, Issue 4, 1999, Pages 185-192

  Hundsdorfer P ^b   Fruehauf, Stefan ^a   Haberkorn, M ^b   Hoft R ^b   Haas, R ^b   Zeller, W J ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

B cell depletion; CD34+ selection; K422 cells; Lymphona; Peripheral blood stem cells; Purging

Indexed keywords

ANTIBODY; AVIDIN; BIOTIN; BOVINE SERUM ALBUMIN; CD34 ANTIGEN; SODIUM CHLORIDE;

ARTICLE; B LYMPHOCYTE; CELL SEPARATION; CONTROLLED STUDY; DEVICE; HUMAN; HUMAN CELL; IMMUNOADSORPTION; INTERMETHOD COMPARISON; LEUKAPHERESIS; LYMPHOMA CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ANTIGENS, CD34; AVIDIN; BIOTIN; CELL SEPARATION; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOMAGNETIC SEPARATION; IMMUNOSORBENT TECHNIQUES; LEUKAPHERESIS; LYMPHOMA, NON-HODGKIN; TUMOR CELLS, CULTURED;

EID: 0344327108     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000040951     Document Type: Article

References (46)

1. Kvalheim G, Sorenson O, Fodstad O, Pihl A, Nustad K, Pharo A, Ugelstad J, Funderud S: Immunomagnetic removal of B-lymphoma cells from human bone marrow: A procedure for clinical use. Bone Marrow Transplant 1988; 3:31-41.
2. Kiesel S, Haas R, Moldenhauer G, Kvalheim G, Pezzutto A, Dörken B: Removal of cells from a malignant B cell line from bone marrow with immunomagnetic beads and with complement and immunoglobulin switch variant mediated cytolysis. Leukemia Res 1987;12:1119-1125.
3. Dreger P, von Neuhoff N, Suttorp M, Löffler H, Schmitz N: Rapid engraftment of peripheral blood progenitor cell grafts purged with B cell-specific monoclonal antibodies and immunomagnetic beads. Bone Marrow Transplant 1995;16:627-629.
4. Alcorn MJ, Holyake TL, Richmond L, Pearson C, Farrell E, Kyle B, Dunlop DJ, Fitzsimons E, Steward WP, Pragnell IB, Franklin IM: CD34-positive cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J Clin Oncol 1996;14: 1839-1847.
5. Hawkins TE, Marley SB, O'Brien SG, Gordon MY, Goldman JM: CD34+ selection in chronic phase chronic myeloid leukaemia: A comparison of laboratory grade columns. Bone Marrow Transplant 1997;20:409-413.
6. Hohaus S, Pfoersich M, Murea S, Abdallah A, Lin YS, Funk L, Voso MT, Kaul S, Schmid H, Wallwiener D, Haas R: Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer. Br J Haematol 1997;97:881-888.
7. Mapara MY, Körner IJ, Hildebrandt M, Bargou R, Krahl D, Reichardt, Dörken B: Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: Comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Blood 1997;89: 337-344.
8. Paulus U, Dreger P, Viehmann K, von Neuhoff N, Schmitz N: Purging peripheral blood progenitor cell grafts from lymphoma cells: Quantitative comparison of immunomagnetic CD34+ selection systems. Stem Cells 1997;15: 297-304.
9. Berenson RJ, Andrews RG, Bensinger WI, Kalamsz, Knitter G, Bruckner CD, Bernstein ID: Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 1988;81:951-955.
10. Johnson RJ, Owen RG, Smith GM, Child JA, Galvin M, Newton LJ, Rawstron A, Major K, Woodhead V, Robinson F, Jack A, Morgan GJ: Peripheral blood stem cell transplantation in myeloma using CD34 selected cells. Bone Marrow Transplant 1996;17:723-727.
11. Widmer L, Pichert G, Jost LM, Stahel RA: Fate of contaminating t(14;18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cells. Blood 1996; 88:3166-3175.
12. Bertolini F, Thomas T, Battaglia M, Gibelli N, Pedrazzoli P, Robustelli dela Cuna G: A new 'two step' procedure for 4.5 log depletion of T and B cells in allogenic transplantation and of neoplastic cells in autologous transplantation. Bone Marrow Transplant 1997;19:615-619.
13. Handgretinger R, Greil J, Schurman U, Lang P, Gonzalez-Ramella O, Schmidt I, Fuhrer R, Niethammer D, Klingebiel T: Positive selection and transplantation of peripheral CD34+ progenitor cells: Feasibility and purging efficacy in pediatric patients with neuroblastoma. J Hematother 1997;6:235-242.
14. Marin GH, Dal Cortivo L, Cayuela JM, Marolleau JP, Pautier P, Cojean-Zelek I, Brice P, Makke J, Benbunan M, Gisselbrecht C: Peripheral blood stem cell CD34+ autologous transplant in relapsed follicular lymphoma. Hematol Cell Ther 1997;39:33-40.
15. McQuaker IG, Haynes AP, Anderson S, Stainer C, Owen RG, Morgan GJ, Lumley M, Milligan D, Fletcher J, Bessell EM, Davis JM, Russell NH: Engraftment and molecular monitoring of peripheral-blood stem-cell transplants for follicular lymphoma: A pilot study. J Clin Oncol 1997;15:2288-2295.
16. Somolo G, Sniecinski I, Odom-Mayron T, Nowicki B, Chow W, Hamasaki V, Leong L, Margolin K, Morgan K, Raschko J, Shibata S, Tetef M, Molina A, Berenson RJ, Forman SJ, Doroshow JH: Effect of CD34+ selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancer. Blood 1997;89: 1521-1528.
17. Di Nicola M, Siena S, Corradini P, Bregni M, Milanesi M, Magni M, Ruffini PA, Revagnani F, Tarella C, Gianni AM: Elimination of bcl-2-IgH-positive follicular lymphoma cells from blood transplants with high recovery of hematopoietic progenitors by the Miltenyi CD34+ cell sorting system. Bone Marrow Transplant 1996;18:1117-1121.
18. McNiece I, Bridell R, Stoney G, Kern B, Zilm K, Recktenwald D, Miltenyi S: Large-scale isolation of CD34+ cells using the Amgen cell selection device results in high levels of purity and recovery. J Hematother 1997;6:5-11.
19. Nordon RE, Haylock DN, Gaudry L, Schindhelm K: Hollow-fibre affinity cell separation system for CD34+ cell enrichment. Cytometry 1996;24:340-347.
20. Schriber JR, Dejbakhsh-Jones S, Kusnierz-Glaz CR, Ginzton N, Still B, Negrin RS, Greenberg P, Strober S: Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation. Exp Hematol 1995;23:1024-1029.
21. Lebkowski JS, Schain LR, Okrongly D, Levinski R, Harvey MJ, Okarma TB: Rapid isolation of human CD34 hematopoietic stem cells -purging of human tumor cells. Transplantation 1992;53:1011-1019.
22. Negrin RS, Kusnierz-Glaz CR, Still BJ, Schriber JR, Chao NJ, Long GD, Hoyle C, Hu WW, Horning SJ, Brown BW, Blume KG, Strober S: Transplantation of enriched and purged peripheral blood progenitor cells from a single apharesis product in patients with Non-Hodgkin's lymphoma. Blood 1995;85:3334-3341.
23. Nimgaonkar M, Kemp A, Lancia J, Ball ED: A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells. J Hematother 1996;5:39-48.
24. Paulus U, Schmitz N, Viehmann K, von Neuhoff N, Dreger P: Combined positive/negative selection for highly effective purging of PBSC grafts: Towards clinical application in patients with B-CLL. Bone Marrow Transplant 1997; 20:415-420.
25. Yamaguchi M, Sawada K, Sato N, Koizumi K, Sekiguchi S, Koike T: A rapid nylon-fiber syringe system to deplete CD14+ cells for positive selection of human blood CD34+ cells. Use of immunomagnetic microspheres. Bone Marrow Transplant 1997;19:373-379.
26. Dyer MJS, Fischer P, Nacheva E, Labastide W, Karpas A: A new human B-cell non-Hodgkin's lymphoma cells line (Karpas 422) exhibiting both t(14;18) and t(4;11) chromosomal translocations. Blood 1990;75:709-714.
27. Slezak SE, Horan PK: Fluorescent in vivo tracking of hematopoietic cells. I. Technical considerations. Blood 1989;74:2172-2177.
28. Matutes E, Owusu-Ankomah K, Morilla R, Marco JG, Houlihan A, Que TH, Catowsky D: The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994;8:1640-1645.
29. Erlanson M, Grönlund E, Löfvenberg E, Roos G, Lindh J: Expression of activation markers CD23 and CD69 in B-cell non-Hodgkin's lymphoma. Eur J Haematol 1998;60:125-132.
30. Ogniben E, Hohaus S, Kvalheim G, Dorken B, Haas R: Successful autologous transplantation of immunomagnetic bead purged bone marrow in non-Hodgkin's lymphoma. Prog Clin Biol Res 1992;377:189-195.
31. Straka C, Kröner C, Dörken B, Kvalheim G: Polymerase chain reaction monitoring shows a high efficacy of clinical immunomagnetic purging in patients with centroblastic-centrocytic non-Hodgkin's lymphoma (letter). Blood 1992; 80:2688-2690.
32. Fruehauf S, Haberkorn M, Höft R, Zeller WJ, Haas R, Hunstein W: Isolation of CD34+ cells from leukapheresis products: Evaluation of lymphoma cell purging; in Wunder E, Serke S, Sovalat H, Henon PH (eds): Hematopoietic Stem Cells: The Mulhouse Manual. Dayton, AlphaMed Press, 1994, pp 247-253.
33. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ: Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994;12:28-36.
34. Berenson RJ, Bensinger WI, Hill RS, Andrews RG, Garcia-Lopez J, Kalamasz D, Still BJ, Spitzer G, Buckner CD, Bernstein ID, Thomas ED: Engraftment after infusion of marrow cells in patients with breast cancer or neuroblastoma. Blood 1991;77:1717-1721.
35. Ogura M, Kagami Y, Suzuki R, Miura K, Uehira K, Kurokawa T, Ito T, Kinishita T, Emi N, Morishima Y, Kodera Y, Ueda R: Phase I/II trial of cure-oriented high-dose chemotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study group. Cancer Chemother Pharmacol 1997; 40(suppl):S51-S57.
36. Schiller EJ, Vescio R, Freytes C, Spitzer G, Sahebi F, Lee M, Wu CH, Cao J, Lee JC, Hong CH, Lichtenstein A, Lill M, Hall J, Berenson R, Berenson J: Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995;86:390-397.
37. Lemoli RM, Fortuna A, Motta MR, Rizzi S, Giudice V, Nannetti A, Martinielli G, Cavo M, Amabile M, Mangianti S, Fogli M, Conte R, Tura S: Concomitant mobilisation of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: Positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells. Blood 1996;87:1625-1634.
38. Moos M, Schultz R, Murea S, Goldschmidt H, Haas R: Monitoring of minimal disease in patients with follicular non-Hodgkin's lymphoma undergoing high-dose therapy with peripheral blood stem cell support. Proc ASH 1997, abstr 340.
39. Gribben JG, Neuberg D, Barber M, Moore J, Pesek KW, Freedman AS, Nadler LM: Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 1994;83:3800.
40. Negrin RS, Pesando J: Detection of tumor cells in purged bone marrow and peripheral-blood mononuclear cells by polymerase chain reaction amplification of bcl-2 translocations. J Clin Oncol 1994;12:1021.
41. Hardingham JE, Kotasek D, Sage RE, Dobrovic A, Gooley T, Dale BM: Molecular detection of residual lymphoma cells in peripheral blood stem cell harvests and following autologous transplantation. Bone Marrow Transplant 1993;11:15.
42. Lopez-Guerrero JA, Bolufer-Gilabert P, Sanz-Alonso M, Baragan Gonzales E, Palau-Perez J, De-la-Rubia-Comos J, Sempere-Talens A, Bonanad-Boix S: Minimal illegitimate levels of cytokeratin 19 expression in mononucleated blood cells detected by a reverse transcription PCR method (RT-PCR). Clin Chim Acta 1997; 263:105-116.
43. Civin CI, Strauss LC, Fackler MJ, Trischmann TM, Wiley JM, Loken MR: Positive stem cell section: Basic Science; in Gross S, Gee AP, Worthington-White DA (eds): Bone Marrow Purging and Processing. Progress in Clinical and Biological Research. New York, Wiley-Liss, 1990, vol 333, pp 387-402.
44. Mohr M, Fietz T, Hoppe B, Koenigsmann M, Knauf WU, Reufi B, Mücke C, Thiel E, Berdel WE: Simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy. Proc ASH 1997, abstr 946.
45. Heimfeld S, Colter M, Corpuz S, Stray KM, Berenson RJ: Combination of Ceprate CD34 column selection followed by a second avidinbiotin negative depletion results in enhanced purging of tumor cells or B-cells. Br J Haematol 1994;87(suppl 1):36, A144.
46. Canals C, Punti C, Picon M, Amill B, Tugues D, Sanchez T, Badell I, Pardo N, Ortega J, Vivancos P: Immunomagnetic purging in autologous bone marrow transplantation, experience in fourteen patients. Prog Clin Biol Res 1992;377:289-296.